SEC Form 4 · accession 0001209191-18-056826
Twist Bioscience Corp · TWST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jan Johannessen
Director
Period of report
Oct 30, 2018
Accepted (ET)
Nov 1, 2018 · 6:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001581280
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $14.00 | Oct 30, 2018 | A | 42,304 | A | — | Oct 29, 2028 | Common Stock | 42,304 | 42,304 | D |
Explanation of responses
- F11/3rd of the shares subject to the option vest and become exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.